BCAT1 and cancer: Flow cytometry analysis showed that CD133, a cancer cell stemness marker 38, was expressed in a higher proportion of L2 and L6 cells expressing scrambled BCAT1 shRNA, and that knockdown of BCAT1 expression significantly reduced the proportion of CD133-positive cells (Figure 4F-G).